Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.
about
Ovarian cancer, the coagulation pathway, and inflammationStructure of human factor VIIa and its implications for the triggering of blood coagulationSpectroscopic Characterization of Successive Phosphorylation of the Tissue Factor Cytoplasmic RegionContribution of tryptophan residues to the CD spectrum of the extracellular domain of human tissue factor: application in folding studies and prediction of secondary structure.Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells.Actions of heparin that may affect the malignant process.Impact of venous thromboembolism and anticoagulation on cancer and cancer survivalTissue factor and PAR2 signaling in the tumor microenvironmentTumors, ticks and tissue factor.Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma.Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.Tissue factor-factor VIIa signaling.Use of mouse models to study the role of tissue factor in tumor biologyTumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor.Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domainCooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development.The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.Tissue factor - a therapeutic target for thrombotic disorders.Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma.The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation.Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant miceThe cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia.Orthotopic injection of breast cancer cells into the mammary fat pad of mice to study tumor growth.Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor.CD40 ligation induces tissue factor expression in human vascular smooth muscle cells.Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms.Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathwaysModeling and simulation of procoagulant circulating tumor cells in flow.A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280.Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis.Inhibition of tissue factor signaling suppresses tumor growthPersistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasionMechanistic coupling of protease signaling and initiation of coagulation by tissue factorTissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration.Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβCardiac tissue factor: roles in physiology and fibrosis.Tissue factor, angiogenesis and tumour progression.Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signalingRole of tissue factor in cancer.Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure.
P2860
Q24816796-B74C2BA3-45D0-4BF9-9EF7-E814784F6617Q27619263-9A08ADF4-1E27-4B6A-9359-92BFBFC893C1Q27658963-040BFD8A-A945-4444-8A96-7EC36F0F37B5Q31944752-3D9F67C0-A2DA-4655-B5EE-6012FE619255Q33322944-47B14434-A22A-4122-8136-6F72EBE9CE2CQ33534337-65E2F76B-8271-48D8-9115-E17B8D467DE5Q33561203-6208A605-B1CB-4B5D-8194-CC5DBD9CDEC3Q33592102-4EC55DF3-F2B8-49F5-9A0B-48F766DE7984Q33710071-1C21F68E-AD40-4CCB-A302-E906E7687060Q33720303-EF86F3F3-F6B1-41E7-8640-F2E206C07C14Q33723243-41D5F3E9-D321-4A7B-8F0C-B953891BCB21Q33726774-6ABFF4B2-876B-474C-BFC1-24D7BFC5A5F7Q33765414-8FD8E449-C4BD-4527-8175-8CFE3B970B22Q33901970-F430BA34-9F78-4620-B971-99B43FB532A0Q34433534-A0505174-AE40-425B-A016-DF955370771CQ34541646-75B30DA2-7347-4713-81EC-E7FAE23673B8Q34568612-264216BA-57E3-4314-8D25-493F3B47699AQ34837564-FD64A2FB-97E3-4F11-BB58-866297A2F820Q35005521-E754472B-632E-439F-B70A-F88C3C8A8302Q35034831-AADBF1F8-D328-4CDA-B82E-AA526FA2A6FDQ35083269-488D1A0B-D092-4E1C-BE8F-39CFAEC23AF3Q35102893-C3963BB9-BA5C-411F-926A-9A1BD3C458CDQ35162196-5496E898-AAAC-4E49-9A9D-2E392CC748B7Q35559979-E574D040-E828-4C4E-A79B-AB11F6D140A3Q35793488-FD5C7248-482F-48F1-B319-637C65CAD629Q35850648-84893E80-C155-4F52-AFF6-EAB0DE35F82EQ35926915-882A114C-F9AC-4E6D-BA01-A8485DA83FD8Q36233784-E242CE3C-A275-448D-AFCD-7CB9BDB57976Q36255171-89DFE5DF-4BD1-4A7B-BC30-AEEBA7227E11Q36375915-3DBAA997-F31A-49A0-A8D8-742B3A382283Q36384586-876D9386-4781-4FF2-87F1-3225970E96DEQ36420521-C07EA57C-EB1E-402D-A52C-E47FEE812393Q36521480-B7CF8229-E1E6-4155-BBBF-F42DCB8A6114Q36621701-01DC53D4-68FD-4920-B6C0-F7ECA0974F71Q36852177-D5D3D24E-D88A-4506-B344-5B4318384E17Q37091115-19F09C7A-9404-48FA-94D1-623B77A09D3DQ37122001-55F0A29B-2202-47CE-AB25-87014F5FCEE1Q37193598-3D9BA96B-D01F-4AC5-8FCA-1DCF6EBF6E55Q37393391-D2671C0C-611D-4E9E-BF73-161E8CBD26C0Q37524393-ED4477E0-583C-46D0-A068-A19B2B066AD2
P2860
Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Requirement for binding of cat ...... ndent experimental metastasis.
@en
Requirement for binding of cat ...... ndent experimental metastasis.
@nl
type
label
Requirement for binding of cat ...... ndent experimental metastasis.
@en
Requirement for binding of cat ...... ndent experimental metastasis.
@nl
prefLabel
Requirement for binding of cat ...... ndent experimental metastasis.
@en
Requirement for binding of cat ...... ndent experimental metastasis.
@nl
P2860
P356
P1476
Requirement for binding of cat ...... ndent experimental metastasis.
@en
P2093
P2860
P304
P356
10.1172/JCI930
P407
P577
1998-04-01T00:00:00Z